CIMAC Data definition

CIMAC Data means CIMAC-generated data in the performance of the Research Project, including, but not limited to, assay output and data on assay validation and performance using Biospecimens.
Sample 1Sample 2Sample 3
CIMAC Data means CIMAC-generated data including, but not limited to, assay output and data on assay validation and performance using clinical trial samples. The CIMAC Data will be jointly owned by the Provider and the CIMAC that generated the data from the Human Material. The CIMAC will own the data they generate that do not relate to a Research Project (for example, improvements to assays that are not directly related to specific Human Material).
Sample 1Sample 2Sample 3

Examples of CIMAC Data in a sentence

  • Each Party agrees that a Party providing Human Material, CIMAC Data, or Results will not be held liable for any loss, harm, illness, or other damage or injury (each a “Liability”) arising from another Party’s receipt, handling, use, or disposal of the Human Material, CIMAC Data, or Results except to the extent such Liability arises from or is due to the gross negligence or willful misconduct of the providing Party.

  • No Party makes any warranties, express or implied, as to any matter whatsoever, including without limitation, as to the quality, fitness for any particular purpose, merchantability, or noninfringement with regard to any Human Material, Cross-Trial Analysis, CIMAC Data, or Results.

  • No Party makes any warranties, express or implied, as to any matter whatsoever, including without limitation, as to the quality, fitness for any particular purpose, merchantability, or noninfringement with regard to the Human Material, any Cross-Trial Analysis, CIMAC Data, or any Results.

  • Each Recipient CIMAC will have full rights to use the CIMAC Data that it generates that is not specifically related to the Research Project or use of the Human Material (for example, improvements to assays that are not directly related to specific Human Material).

  • Each Recipient CIMAC will transfer the CIMAC Data it generates from the Human Material as well as all Results to CIDC promptly after such CIMAC Data or Results are available.

  • CIDC will transfer Clinical Data, Results, and CIMAC Data to NCI promptly after each data set is complete, but no later than at the time of publication, or, if no publication, then twelve (12) months from the completion of the relevant data set.

  • For clarity, CIMAC Data, Clinical Data, and Results from Cross-Trial Analysis will also be submitted to the controlled-access data archives or data commons described in 4(h) once the Cross-Trial Analysis has been published in manuscript form, for sharing with approved requestors from the general research community.

  • The Recipient CIMAC will solely own all CIMAC Data that it generates that is not specifically related to a Research Project (for example, improvements to assays that are not directly related to specific Human Material).

  • Provider will have use of the Results and the CIMAC Data generated from the Human Material without accounting to the other Party(ies) after the expiration of the Exclusivity Period and in compliance with the Sections on Publication and Authorship of this Agreement.

  • If consented to by the NCI/Pharma Collaborator, the members of the Partnership for Accelerating Cancer Therapies (PACT) may have access to the CIMAC Data, Results, and the Clinical Data needed to interpret the CIMAC Data and Results post-publication of each Clinical Trial’s primary endpoint but prior to submission of the data to the controlled-access databases described in (h).

Related to CIMAC Data

  • DXC Data means the content, information and data pertaining to DXC and/or DXC Customers that is submitted to or accessed by Supplier pursuant to this Agreement. DXC Data may include, but is not limited to the following, each of which is defined more fully herein, DXC Sensitive Information, Confidential Information, Personal Information, and Protected Health Information (PHI).

  • biometric data means personal data resulting from specific technical processing relating to the physical, physiological or behavioural characteristics of a natural person, which allow or confirm the unique identification of that natural person, such as facial images or dactyloscopic data;

  • traffic data means any data processed for the purpose of the conveyance of a communication on an electronic communications network or for the billing thereof;

  • genetic data means personal data relating to the inherited or acquired genetic characteristics of a natural person which give unique information about the physiology or the health of that natural person and which result, in particular, from an analysis of a biological sample from the natural person in question;

  • Public data means the objective, factual data on which policy decisions are based and on which public services are assessed, or which is collected or generated in the course of public service delivery.

  • Non-Public Data means Customer Data, other than Personal Data, that is not subject to distribution to the public as public information. It is deemed to be sensitive and confidential by Customer because it contains information that is exempt by statute, ordinance or administrative rule from access by the general public as public information. Non-Public Data includes any data deemed confidential pursuant to the Contract, otherwise identified by Customer as Non-Public Data, or that a reasonable person would deem confidential.

  • GLO Data means any data or information owned by the GLO, including PII or SPI as defined below, that Provider creates, obtains, accesses (via records, systems, or otherwise), receives (from the GLO or on behalf of the GLO), or uses in the performance of the Contract or any documents related thereto.

  • UNICEF Data means any and all information or data in digital form or processed or held in digital form that

  • Electronic Data means information, facts or programs stored as or on, created or used on, or transmitted to or from computer software, including systems and applications software, hard or floppy disks, CD-ROMS, tapes, drives, cells, data processing devices or any other media which are used with electronically controlled equipment.

  • Electronic Data Interchange (EDI means technology that provides transaction related details, including invoice number(s), pay dates, and other identifying information as appropriate for each transaction.

  • Electronic Data Room means the electronic data room established by or on behalf of the Company in connection with the transactions contemplated hereby.

  • Electronic Data Interchange or “EDI technology” means the computer-to-computer exchange of business transactions in a standardized, structured electronic format.

  • Regulatory Materials means regulatory applications, submissions, notifications, registrations, or other filings made to or with a Regulatory Authority that are necessary or reasonably desirable in order to develop, manufacture, market, sell or otherwise commercialize a product in a particular country or regulatory jurisdiction. Regulatory Materials include INDs, XXXx and NDAs (as applications, but not the approvals with respect thereto).

  • Regulatory Data means any and all research data, pharmacology data, chemistry, manufacturing, and control data, preclinical data, clinical data or all other documentation submitted, or required to be submitted, to Regulatory Authorities in association with regulatory filings for the Product in the Field (including any Drug Master Files (DMFs), Chemistry, Manufacturing and Control (“CMC”) data, or similar documentation).

  • Program Know-How means all Information and inventions that are conceived, discovered, developed, or otherwise made by or on behalf of either Party or its Affiliates or licensees, solely or jointly with the other Party or its Affiliates or licensees, under this Agreement.

  • Regulatory Documentation means all applications, registrations, licenses, authorizations and approvals (including all Approvals), all correspondence submitted to or received from Regulatory Authorities (including minutes and official contact reports relating to any communications with any Regulatory Authority), all supporting documents and all Clinical Trials and tests, including the manufacturing batch records, relating to a Product, and all data contained in any of the foregoing, including all regulatory drug lists, advertising and promotion documents, adverse event files and complaint files.

  • Third Party Data has the meaning set forth in Section 9.3(a).

  • Customer Materials any materials, data, information, software, equipment or other resources owned by or licensed to You and made available to Us pursuant to facilitating Your use of the Services, including Customer Data.

  • Postconsumer material means a material or finished product that has served its intended use and has been discarded for disposal or recovery, having completed its life as a consumer item. Postconsumer material is a part of the broader category of “recovered material.”

  • Regulatory Filings means any submission to a Regulatory Authority of any appropriate regulatory application together with any related correspondence and documentation, and will include any submission to a regulatory advisory board, marketing authorization application, and any supplement or amendment thereto.

  • Portfolio Data means the Key Terms in relation to all outstanding Trades between you and us in a form and standard that is capable of being reconciled. The information comprising the Portfolio Data for Portfolio Data Delivery Date will be prepared as at the close of business New York time on the immediately preceding Business Day.

  • Supplier Materials has the meaning set out in clause 8.1(g);

  • Post-consumer material means a material or finished product that has served its intended use and has been discarded for disposal or recovery, having completed its life as a consumer item. Post consumer material is a part of the broader category of "recycled content."

  • Program Information is defined in Section 13.8(a)(i).

  • Licensed Data means the data licensed by the LME to the Licensee set out in the Order Form and further defined in Schedule 1 (Licensed Data);

  • Regulatory Filing means any approvals, licenses, registrations, submissions and authorizations, and applications therefor, including IND, NDA, BLA, drug dossier or drug master file filed, or Marketing Approval obtained, with respect to an Option Product, Licensed Product or Companion Diagnostic, as applicable, in the Field, including all amendments, supplements, annual reports and the like thereof or therefor filed with or otherwise provided to the applicable Regulatory Authority.